Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients

scientific article published on 11 March 2019

Prescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4048/JBC.2019.22.E14
P932PMC publication ID6438827
P698PubMed publication ID30941236

P50authorYu Rang ParkQ61108816
Jong Won LeeQ87755828
Sei Hyun AhnQ88063206
Yura LeeQ88633385
Il Yong ChungQ90156944
Sae Byul LeeQ90156951
P2093author name stringByung Ho Son
Il Yong Chung
P2860cites workDiscontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?Q52652540
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upQ59567527
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsQ29547513
Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer SocietyQ31113303
A hard pill to swallow: a qualitative study of women's experiences of adjuvant endocrine therapy for breast cancer.Q33795923
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.Q33927985
A review of breast cancer survivorship issues from survivors' perspectivesQ34340570
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused updateQ34421634
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancerQ36292773
Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancerQ36300005
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialQ36680024
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic reviewQ36713559
Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.Q36775354
Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)Q36901989
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancerQ37010590
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.Q37130218
The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.Q37185856
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effectsQ37671448
Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.Q38128209
Adherence to endocrine therapy in breast cancer adjuvant and prevention settingsQ38179905
Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence researchQ38225433
A De-identification method for bilingual clinical texts of various note types.Q38418332
The association between trajectories of endocrine therapy adherence and mortality among women with breast cancer.Q39813083
Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast CancerQ40879609
Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysisQ44896647
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancerQ45079168
Mortality impact of less-than-standard therapy in older breast cancer patientsQ46835873
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)86-95
P577publication date2019-03-11
P1433published inJournal of breast cancerQ26842109
P1476titlePrescription Refill Gap of Endocrine Treatment from Electronic Medical Records as a Prognostic Factor in Breast Cancer Patients
P478volume22

Search more.